Sara Bonstein
Director of Finance/CFO bei INSMED INCORPORATED
Vermögen: 3 Mio $ am 31.03.2024
Profil
Sara M.
Bonstein is an Independent Director at scPharmaceuticals, Inc., Xilio Therapeutics, Inc., and a Chief Financial Officer at Insmed, Inc. She previously worked as a Director-Development Finance at ImClone LLC from 2004 to 2014, Finance Director at Eli Lilly & Co., CFO, Secretary, Treasurer & Executive VP at Advaxis, Inc. from 2014 to 2018, and Secretary, Chief Operating & Financial Officer at OncoSec Medical, Inc. from 2018 to 2020.
She holds an undergraduate degree from The College of New Jersey and an MBA from Rider University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INSMED INCORPORATED
0,08% | 09.01.2024 | 114 051 ( 0,08% ) | 3 Mio $ | 31.03.2024 |
SCPHARMACEUTICALS, INC.
-.--% | 29.02.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Sara Bonstein
| Unternehmen | Position | Beginn |
|---|---|---|
| INSMED INCORPORATED | Director of Finance/CFO | 31.01.2020 |
| SCPHARMACEUTICALS INC. | Director/Board Member | 08.07.2020 |
| XILIO THERAPEUTICS, INC. | Director/Board Member | 17.08.2021 |
Ehemalige bekannte Positionen von Sara Bonstein
| Unternehmen | Position | Ende |
|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Director of Finance/CFO | 30.01.2020 |
| AYALA PHARMACEUTICALS, INC. | Director of Finance/CFO | 30.04.2018 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01.02.2014 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Ausbildung von Sara Bonstein
| The College of New Jersey | Undergraduate Degree |
| Rider University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| INSMED INCORPORATED | Health Technology |
| ONCOSEC MEDICAL INCORPORATED | Health Services |
| SCPHARMACEUTICALS INC. | Health Technology |
| XILIO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
